Dr. Carlo M. Contreras, MD

Claim this profile

Ohio State University Comprehensive Cancer Center

Studies Melanoma
Studies Skin Cancer
3 reported clinical trials
4 drugs studied

Area of expertise

1

Melanoma

Carlo M. Contreras, MD has run 2 trials for Melanoma. Some of their research focus areas include:

Stage I
Stage II
Stage III
2

Skin Cancer

Carlo M. Contreras, MD has run 2 trials for Skin Cancer. Some of their research focus areas include:

Stage I
Stage II
Stage III

Affiliated Hospitals

Image of trial facility.

Ohio State University Comprehensive Cancer Center

Clinical Trials Carlo M. Contreras, MD is currently running

Image of trial facility.

Flu Vaccine

for Melanoma

This phase I trial investigates the effects of influenza vaccine in treating patients with stage I-IV melanoma. While intramuscular administration of influenza vaccine provides immunization against the influenza virus, giving influenza vaccine directly into the tumor (intralesional) may decrease the size of the injected melanoma tumor, or the extent of the melanoma within the body.

Recruiting

1 award

Phase 1

4 criteria

Image of trial facility.

EMLA Cream

for Pain in Skin Cancer

This phase II trial tests how well EMLA topical cream works in treating pain in patients with skin cancers receiving Technetium 99 injections for a lymphoscintigraphy mapping procedure. A lymphoscintigraphy mapping procedure is used to find the main or lead lymph node (tissue that fight infection) so it can be removed and checked for tumor cells. Using lymphoscintigraphy to highlight and then surgically remove lymph nodes is standard way to treat skin cancer for many patients. The Technetium 99 injections used for lymphoscintigraphy can be briefly painful due to the sensitivity of the nerve endings in the skin. The EMLA topical cream, which contains a numbing medicine to block pain from nerve endings, has been studied in breast cancer patients with a difference in pain reported, but this is the first time it has been studied in patients undergoing lymphoscintigraphy for skin cancer. This study may help researchers learn whether the use of EMLA cream may improve the associated pain at the time of the lymphoscintigraphy procedure.

Recruiting

0 awards

Phase 2

More about Carlo M. Contreras, MD

Clinical Trial Related

1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Carlo M. Contreras, MD has experience with

  • Transcutaneous Sensors
  • Quadrivalent Inactivated Influenza Vaccine
  • Eutectic Mixture Of Local Anesthetics
  • Questionnaire Administration

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Carlo M. Contreras, MD specialize in?

Is Carlo M. Contreras, MD currently recruiting for clinical trials?

Are there any treatments that Carlo M. Contreras, MD has studied deeply?

What is the best way to schedule an appointment with Carlo M. Contreras, MD?

What is the office address of Carlo M. Contreras, MD?

Is there any support for travel costs?